Patent · US Active

Compounds for activating TGF-beta signaling

US8410138B2 · kind B2 · utility

2Cited by
0References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 12, 2011
Grant dateApr 2, 2013
Priority date—
Expiry dateDec 12, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for treatment and prevention of disorders and conditions characterized by reduced TGF-β signaling are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.